These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6740735)

  • 1. Urinary hydroxyphenytoin/creatinine ratios as an index of compliance in adult epileptic patients on phenytoin therapy.
    Rambeck B; May T
    Ther Drug Monit; 1984; 6(2):164-72. PubMed ID: 6740735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.
    Bourgeois BF; Wad N
    Ther Drug Monit; 1985; 7(4):405-10. PubMed ID: 4082240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin metabolism during pregnancy.
    Eadie MJ; McKinnon GE; Dickinson RG; Hooper WD; Lander CM
    Eur J Clin Pharmacol; 1992; 43(4):389-92. PubMed ID: 1451718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism.
    Maguire JH
    Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
    Ball DE; McLaughlin WS; Seymour RA; Kamali F
    J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatographic determination of m- and p-hydroxyphenytoin in the urine of epileptic patients.
    Shimada K; Wakabayashi H; Sato A
    J Chromatogr; 1985 May; 339(2):331-7. PubMed ID: 4008572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct high-performance liquid chromatographic analysis of p-hydroxyphenyl-phenylhydantoin glucuronide, the final metabolite of phenytoin, in human serum and urine.
    Vree TB; Steegers-Theunissen RP; Baars AM; Hekster YA
    J Chromatogr; 1990 Apr; 526(2):581-9. PubMed ID: 2362000
    [No Abstract]   [Full Text] [Related]  

  • 8. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy.
    Aliwarga T; Cloyd JC; Goel V; Brundage RC; Marino SE; Leppik IE; Remmel RP
    Ther Drug Monit; 2011 Feb; 33(1):56-63. PubMed ID: 21233690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.
    Houghton GW; Richens A; Leighton M
    Br J Clin Pharmacol; 1975 Jun; 2(3):251-6. PubMed ID: 1234505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of phenytoin and hydroxyphenytoin in human urine.
    Sato A; Shimada K; Izumo Y; Sakaguchi T
    J Chromatogr; 1983 Jun; 275(1):97-105. PubMed ID: 6874875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical urinary phenytoin metabolite (S)/(R) ratios in CYP2C19*1/*2 patients.
    Argikar UA; Cloyd JC; Birnbaum AK; Leppik IE; Conway J; Kshirsagar S; Oetting WS; Klein EC; Remmel RP
    Epilepsy Res; 2006 Sep; 71(1):54-63. PubMed ID: 16815679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth.
    Kamali F; McLaughlin WS; Ball DE; Seymour RA
    J Clin Periodontol; 1999 Dec; 26(12):802-5. PubMed ID: 10599907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive method for the determination of phenytoin in plasma, and phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in urine by high-performance liquid chromatography.
    Maya MT; Farinha AR; Lucas AM; Morais JA
    J Pharm Biomed Anal; 1992; 10(10-12):1001-6. PubMed ID: 1298355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo.
    Caraco Y; Muszkat M; Wood AJ
    Pharmacogenetics; 2001 Oct; 11(7):587-96. PubMed ID: 11668218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of urinary excretion of p-hydroxyphenytoin in healthy subjects given phenytoin.
    Dickinson RG; Hooper WD; Patterson M; Eadie MJ; Maguire B
    Ther Drug Monit; 1985; 7(3):283-9. PubMed ID: 4049465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the interaction between omeprazole and phenytoin in epileptic patients.
    Andersson T; Lagerström PO; Unge P
    Ther Drug Monit; 1990 Jul; 12(4):329-33. PubMed ID: 2396305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
    Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
    Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of diphenylhydantoin (phenytoin) during pregnancy.
    Landon MJ; Kirkley M
    Br J Obstet Gynaecol; 1979 Feb; 86(2):125-32. PubMed ID: 427051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.